WhiteSwell Medical
Acute Decompensated Heart Failure Treatment
Startup B Health Tech & Life Sciences Est. 2014
Total Raised
$30M
B
Last Round
$30M
1 rounds
Investors
2
2 public
Team
4
11-50 employees
Confidence
90/100
News
5
articles
Patents
1
About
WhiteSwell Medical is a science-driven company dedicated to improving treatment of acute decompensated heart failure (ADHF), a primary cause of repeat hospitalization and emergency room visits. The company is developing a minimally invasive, catheter-based approach designed to more efficiently remove excess interstitial fluid in patients with ADHF by enhancing the natural fluid-removal process of the lymphatic system.
Classification
Sector
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target Customer
Healthcare & Life SciencesHealthcareProviders
Business Model
B2B
Tags
cathetersminimally-invasivecardiovascularheart-failuremedical-devicesmedical-technologies
Funding & Events
Dec 2018
B Round $30M
RA Capital Management, InCube Ventures
News (5)
Jan 26, 2022 · www.businesswire.com
WhiteSwell Adds Experienced Executives to its Senior Management Team
Jan 19, 2021 · www.medgadget.com
growth-positive
Catheter Stimulates Lymphatic Drainage for Heart Failure Treatment: Interview with Eamon Brady, CEO of WhiteSwell
Customers
Dec 16, 2020 · www.businesswire.com
WhiteSwell Strengthens Patent Portfolio for Treatment of Acute Decompensated Heart Failure With Newly Issued U.S. Patent
Jan 24, 2019 · www.siliconrepublic.com
Growth-Positive
Europe Start-up 100: 25 medtech and life sciences start-ups to watch in 2019
CustomersInvestmentPartners
Dec 11, 2018 · www.calcalistech.com
growth-positive
Israeli Medical Device Company WhiteSwell Raises $30 Million
Investment
Details
Product Stage
R&D
Employees
11-50
Exact Count
38
District
Center District
Founded
2014
Registrar
515130060
Crunchbase
whiteswell
Locations
Shefayim, Israel
Galway, Ireland
2225 East Bayshore Road, Palo Alto, CA, USA
Links
Website
LinkedIn
Twitter
Admin
Last Update
Oct 30, 2024
Verified by
Yotam Maman
Missing
video or image, markets, not claimed
Team (4)
Eamon Brady
CEO
Ronan Keating
VP R&D
Jill Amstutz (Velasquez)
VP Strategic Marketing
Martin Keegan
VP of Technical Operations
Internal
Created by
Jenny Sotnik-Talisman (genys30@yahoo.com)
Created
2018-12-11T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)